{'fraction_non_alphanumeric': 0.04797441364605544, 'fraction_numerical': 0.04157782515991471, 'mean_word_length': 5.387755102040816, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Effectiveness of the South African expanded program of immunization against hepatitis B in children infected with human immunodeficiency virus‐1 living in a resource‐limited setting of Kwazulu‐Natal

Prevalence of Human‐Immunodeficiency‐Virus/Hepatitis‐B‐virus (HIV/HBV) coinfection and HBV vaccination response in children are unknown in Kwazulu‐Natal. This study included 183 HIV‐infected and 108 HIV‐uninfected children aged between 5 and 15 years screened for HBV infection and vaccination. HBV infection occurred in 2.1% and 0% of HIV‐infected and uninfected children respectively. Serological response to immunization was shown in 15.8% and 61.1% of HIV‐infected and uninfected children, respectively (P < 0.001). Even if prevalence of HBV infection was low in these cohorts, HIV‐infected children will stay at risk of infection if the vaccine schedule is not adapted. J. Med. Virol. 89:182–185, 2017. © 2016 Wiley Periodicals, Inc.